Trial Profile
An observational, open label trial of lacosamide in children and young adult with symptomatic epilepsy caused by malformations of cortical development
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 25 Feb 2016 New trial record